Increased prevalence of HBV envelope mutants in Taiwan: An emerging public health risk or a false alarm?

Gastroenterology

Volumn 143, Issue 2, 2012, Pages 290-293

  Shouval, Daniel ^a   Locarnini, Stephen ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; POLYCLONAL ANTIBODY; VIRUS DNA;

HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOLOGICAL MEMORY; LIVER CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; REVIEW; SEROPREVALENCE; TAIWAN; VACCINATION; VIRUS ENVELOPE; VIRUS LOAD; VIRUS MUTATION; VIRUS NEUTRALIZATION; VIRUS TRANSMISSION;

EID: 84864245449     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.06.026     Document Type: Editorial

References (17)

1. World Health Organization http://www.who.int 2010
2. A.R. Zanetti, P. Van Damme, D. Shouval The global impact of vaccination against hepatitis B: a historical overview Vaccine 26 2008 6266 6273
3. J.M. Pawlotsky The concept of hepatitis B virus mutant escape J Clin Virol Suppl 1 2005 S125 S129
4. S.A. Locarnini, L. Yuen Molecular genesis of drug-resistant and vaccine-escape HBV mutants Antivir Ther 15 2010 451 461
5. O.V. Nainan, M.L. Khristova, K. Byun Genetic variation of hepatitis B surface antigen coding region among infants with chronic hepatitis B virus infection J Med Virol 68 2002 319 327
6. U. Protzer-Knolle, U. Naumann, R. Bartenschlager Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation Hepatology 1998 27254 27263
7. G. McMahon, P.H. Ehrlich, Z.A. Moustafa Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients Hepatology 15 1992 757 766
8. S. Kamili, V. Sozzi, G. Thompson Efficacy of hepatitis B vaccine against antiviral drug-resistant hepatitis B virus mutants in the chimpanzee model Hepatology 49 2009 1483 1491
9. D.S. Chen, N.H. Hsu, J.L. Sung A mass vaccination program in Taiwan against hepatitis B virus infection in infants hepatitis B surface antigen-carrier mothers JAMA 257 1987 2597 2603 (Pubitemid 17068065)
10. S.M. Chen, C.M. Kung, W.J. Yang Efficacy of the nationwide hepatitis B infant vaccination program in Taiwan J Clin Virol 52 2011 11 16
11. H.Y. Hsu, M.H. Chang, Y.H. Ni Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan Gut 53 2004 1499 1503
12. H.Y. Hsu, M.H. Chang, Y.H. Ni No increase in prevalence of hepatitis B surface antigen mutant in a population of children and adolescents who were fully covered by universal infant immunization J Infect Dis 2010 2010 1192 1200
13. M-W. Lai, T-Y. Lin, K-C. Tsao Increased seroprevalence of HBV DNA with mutations in the S gene among individuals greater than 18 years old after complete vaccination Gastroenterology 143 2012 400 407
14. P. Wagner, D. Shouval, B. Genton Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine Vaccine 5 24 2006 2781 2789
15. Q. Ma, Y. Wang Comprehensive analysis of the prevalence of hepatitis B virus escape mutations in the major hydrophilic region of surface antigen J Med Virol 84 2012 198 206
16. H. Komatsu, A. Inui, T. Sogo Hepatitis B surface gene 145 mutant as a minor population in hepatitis B virus carriers BMC Res Notes 5 2012 22
17. S. Shahmoradi, Y. Yahyapour, M. Mahmoodi High prevalence of occult hepatitis B virus infection in children born to HBsAg positive mothers despite prophylaxis with hepatitis B vaccination and HBIG J Hepatol 2012 May 19 [Epub ahead of print]